Bupropion Increased More than Five Times the Systemic Exposure to Aripiprazole: An In Vivo Study in <i>Wistar albino</i> Rats
<b>Background/Objectives</b>: In psychiatric disorders, antipsychotics and antidepressant medication are often administered together. Aripiprazole, a third-generation antipsychotic drug, is extensively metabolized by CYP2D6 and CYP3A4 isoenzymes, while bupropion, used in depressive disor...
Saved in:
| Main Authors: | Iulia-Maria Ciocotișan, Dana Maria Muntean, Laurian Vlase |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Metabolites |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-1989/14/11/588 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of ABCB1 polymorphisms on aripiprazole and dehydroaripiprazole plasma concentrations
by: Francisco José Toja-Camba, et al.
Published: (2025-01-01) -
Efficacy of varenicline versus bupropion for smoking cessation: A systematic review and meta-analysis of randomized controlled trials
by: Ashish R. Patel, et al.
Published: (2023-05-01) -
Comparison of the efficacy of venlafaxine and bupropion in the treatment of depressive episode in patients with bipolar II disorder
by: Ahmad Fakhri, et al.
Published: (2023-03-01) -
Aripiprazole use as a cause of dopamine agonist failure in the treatment of prolactinomas
by: Edward Mignone, et al.
Published: (2025-01-01) -
Otizm ve tourette sendromu birlikteliğinde düşük doz aripiprazol monoterapisinin etkinliği: olgu sunumu
by: Necati Uzun
Published: (2018-01-01)